Professional Documents
Culture Documents
1F, Gyeonggi R&DB Center/226, 2F, GSBC, 105 Gwanggyo-Ro, Yeongtong-Gu, Suwon-Si, Gyeonggi-Do, Korea Tel. +82-31-888-5100 Fax. +82-31-888-5105
1F, Gyeonggi R&DB Center/226, 2F, GSBC, 105 Gwanggyo-Ro, Yeongtong-Gu, Suwon-Si, Gyeonggi-Do, Korea Tel. +82-31-888-5100 Fax. +82-31-888-5105
www.genoss.com
www.monalisafiller.com
CAT-MO.E(Rev.6, 2002)
Contents
Hy-BRID Technology 05
Safety 06
Ergonomic Design 07
Global Network 08
Product Range 09
Hyaluronic Acid Dermal Filler
Product Line up
Hy-BRID Technology Safety
1
Performance Test Genoss Research Institute
1 2
Viscoelasticity Lattice Structure Standard Result
(SEM, Scanning Electron Microscope)
Appearance No impurities, transparent and colorless gel Pass
3
HA Concentration 18 ~ 22 mg 20.1 mg
pH 6.5 ~7.5 7.00
Residual BDDE < 2 ppm Not Detected
G' and G" (Pa)
Easy Operation
Ergonomically designed grips and push rods provide accurate and safe treatment with constant injection forces. MONALISA is a cross-linked hyaluronic acid filler. It is currently registered and sold in 24 countries outside
It allows the user to perform various injection technique according to treatment site. Asia, Europe, the Middle East and Latin America based on Genoss’ overseas certification.
Grip
Comfort grip
Russia
Comfort grip
Germany Ukraine Kyrgyzstan
Uzbekistan
United Kingdom Turkey
Anti-Slip Switzerland China
Italy Cyprus
Spain
Egypt Iran Mexico
India Vietnam
Philippines
Needle Colombia
Malaysia
Ecuador Brazil
Indonesia
Thin-wall Needle
Argentina
Regular needle
1. Compared to regular needles, the inner diameter is wider. Thin-wall needle can make smooth injection.
7 8
Product Range
1
Concentration 20 mg/mL
RD
HA
m 100
Epidermis
Dermis
ULTRA
Subcutaneous
tissue
9
Brand Story
MONALISA Filler
Find the answer in a masterpiece.
The Mona Lisa, work of Renaissance genius artist Leonardo da Vinci,
is loved to these days with a mysterious and natural smile.